It is important to note that a myeloablative conditioning regimen followed by HSCT is the standard approach in pediatric patients with myelodysplasia, particularly in patients with high-risk features such as monosomy 7 (often found in patients with GATA2 related MDS). The gene discussed is GATA2; the disease is myelodysplastic syndrome.